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Supplementary Figures 
 
Figure S1. Ontological and overrepresentation analysis of the differentially expressed 
genes in hypoxia. (A-J) PANTHER was used to classify the genes involved in each subset of 
hypoxia induced and repressed genes according to GO terms, and PANTHER protein class 
and pathway terms. Highlighted in blue are the terms whose gene count was present in the 
top 20 of only one of the lists (induced or repressed).   
  
Supplementary Figure S2 is in its separate file. 
 
Figure S2. REST mRNA expression across multiple cell lines. REST mRNA expression 
compiled from publically available microarray datasets of 1562 different cell lines. The graph 
was compiled with Genevestigator and shows the human REST mRNA expression levels (xx 
axis) and number of samples (yy). 
 
  
  
 
 
Figure S3. REST is expressed in the nucleus and cytoplasmic of normoxic HEK293 cells. 
(A) Nuclear and cytoplasmic extracts of HEK293 cells where prepared and immunobloted for 
REST, Lamin A/C (nuclear loading) and α-Tubulin (cytoplasmic loading). 20 to 40 ug of 
total lysates where loaded per experiment, in a total of 8 independent experiments. (B) 
Densitometry of (A), for REST, Lamin A/C and α-Tubulin normalized to the cytoplasmic 
expression level. Data are represented as mean ± SEM, n = 8 independent experiments. 
 
  
  
 
 
 
 
 
Figure S4. REST accumulates in the nucleus of hypoxic MCF10A cells. (A) Cells where 
exposed to hypoxia (1% oxygen) for the indicated time points. Nuclear and cytoplasmic 
extracts of MCF10A cells where prepared and immunobloted for REST, Lamin (nuclear 
loading) and α-Tubulin (cytoplasmic loading). (B) Densitometry of (A). Data are represented 
as mean ± SEM, n = 3 independent experiments. 
  
 
 
 
 
 
 
Figure S5. Development and validation of a RE1 responsive Gaussia luciferase 
promoter reporter construct (pRE1-TK-GLuc). (A) The pTK-GLuc Vector is a 
mammalian expression vector that encodes the secreted luciferase from the copepod Gaussia 
princeps as a reporter, under the control of the constitutive Herpes Simplex Virus thymidine 
kinase promoter (P hsv tk)). Gaussia Luciferase (GLuc) is a 20 kDa protein encoded by a 
"humanized" sequence, and it contains a native signal peptide at the N-terminus that allows it 
to be secreted from mammalian cells into the cell culture medium (Tannous et al., 2005; 
Verhaegen and Christopoulos, 2002). pTK- GLuc has a multiple cloning site (MCS) 
downstream of the GLuc stop codon, XhoI and NotI were chosen as entry sites for the RE1 
sequence. Ori indicates the bacterial replication origin of replication (pMB1), for the 
propagation and maintenance (sub cloning) in E. coli. (https://www.neb.com/products/n8084-
ptk-gluc-vector). (B) The pRE1-TK-GLuc REST responsive construct was developed by 
incorporating the RE1 originally found in the SCN2A gene (Mori et al., 1992) into the vector 
pTK-GLuc. The pTK-GLuc reporter construct, constitutively expresses Gaussia luciferase 
under the control of the constitutive Herpes Simplex Virus thymidine kinase promoter, 
incorporation of the RE1 site is aimed at assessing how strongly REST binds and inhibits 
transcription. (C) HEK293 cells were transfected with a vector expressing Gaussia luciferase 
under the control of the TK promoter (pTK-GLuc) for constitutive expression, or with the 
REST responsive pRE1-TK-GLuc construct. Results are shown as REST repressor activity 
(dividing the RLU of pTK- GLuc by pRE1-TK-GLuc). REST knockdown was performed 
using REST specific (REST-RNAi) or scrambled control RNAi. Data are represented as 
mean ± SEM, n = 3 independent experiments. * p<0.05. AU = Arbitrary Units.  
  
  
 
Figure S6. REST protein stability is not affected by hypoxia. (A) HEK293 cells were pre-
conditioned to hypoxia or normoxia for 24 hours and subjected to cycloheximide (CHX) 
pulse-chase treatments for the indicated time points before whole cell extracts were prepared 
and immunoblotted as indicated for HIF-1α, REST and β-actin (n = 4). Densitometric 
analysis of (A) for REST (B), HIF-1α (C) and β-actin (D) are presented. 
  
  
 
 
Figure S7. Technical validation of RNA-seq and RNAi mediated knockdown 
experiments. (A) EdgeR and Cuffdiff were used to independently estimate the magnitude 
and significance of the gene expression changes, with an agreement between 70 to 85%. 
Commonly differentially expressed genes (q-value<0.05) were selected for further analysis. 
REST-Dependent genes repressed in normoxia (21% O2) were defined as those genes whose 
expression was increased in normoxic cells treated with REST-RNAi as compared to Ctrl-
RNAi treated cells. Hypoxia-Repressed and -Induced genes were those genes whose 
expression decreased or increased, respectively, in hypoxic cells (1% O2) as compared to 
normoxic cells. REST-Dependent genes repressed in hypoxia were those genes whose 
expression was decreased in hypoxic cells, but not when hypoxic cells were treated with 
REST-RNAi. REST-Dependent hypoxia induced genes were defined as those genes that were 
induced by hypoxia, and further induced by REST-RNAi treatment in hypoxia. (B) Around 
15 million mapped reads were obtained consistently between the 12 different samples, 
independent of treatment and biological replicate. (C) Quality of the reads as assessed by 
Q30 parameter which indicates an accuracy of 99.9 % of base calling, more than 90% of the 
mapped reads had an QC30. (D) The percentage of reads mapping to intronic, exonic and  
intergenic regions is shown for each RNA-seq sample. The high percentage of exonic reads 
in our poly(A)+ RNA samples indicates good enrichment of poly(A)+ RNA and low DNA 
contamination. Furthermore, it indicates that our sequencing matches well with known exon 
annotation. (E) Alignment of reads by TopHat to human reference genome hg19 (GRCh37) 
from sample 1 (21%-Ctrl_RNAi) and sample 2 (21%-REST_RNAi) to the REST gene on 
chromosome 4q11. Visualized with IGV 2.3.32. RNA-seq reads mapping to the REST gene 
show a preferential allocation to exons, indicating poly(A)+ RNA enrichment, and a marked 
decreased in the number of reads upon REST-RNAi treatment indicating the validity of 
RNA-seq to accurately measure differences in gene expression.  
 
  
  
 
 
Figure S8. Agarose gel and Bioanalyzer electropherogram of total RNA used in the 
RNA-Seq experiment. (A) 2 µg of RNA from each experimental conditions and biological 
replicate was loaded into a 2% agarose gel with ethydium bromide and run on TAE buffer. 
18S and 28S indicate ribosomal RNA subunits. gDNA, indicates genomic DNA 
contamination. (B) Around 100 ng of RNA were run on Eukaryote Total RNA Nano 
bioanalyzer from Agilent technologies. Distinct ribosomal peaks corresponding to 18S and 
28S eukaryotic RNA and a relatively flat baseline between the 5S and 18S ribosomal peaks 
can be seen for all samples, as well as RIN=10 in all samples. Marker indicates the peak from 
an internal control molecular weight marker. N indicates the biological replicate, 21% and 
1% indicate the oxygen percentage, Ctrl-RNAi and REST-RNAi indicate scramble control 
and REST targeting siRNA, respectively.   
  
Figure S9. Validation of REST mRNA knockdown by qPCR, on the mRNA samples 
used for RNA-seq and by western blot. (A) HE293 mRNA used for RNA-seq analysis 
where exposed to normoxia (21 % oxygen), hypoxia (1 % Oxygen) with Control-RNAi or 
REST-RNAi. Each graph shows one biological replicate. Data is normalized to control RNAi 
in normoxia or hypoxia. (B) HEK293 cells where treated as described in (A), in normoxia, 
and immunobloted with the indicated antibodies. (C) Densitometry of 3 independent 
experiments using the optimized REST siRNA quantity: 100 pmol. 
  
 Figure S10. Analysis of cell death under hypoxia during REST knockdown using 
siRNA. HEK293 cells where treated with non targeting control siRNA (siNT) or REST 
siRNA, exposed to normoxia or hypoxia (1% oxygen) for 48 hours. (A, B) Cells where 
collected and analysed for cell viability using the Trypan Blue exclusion assay, total alive  
(A) or dead cells are presented (B) as a percentage of the total population counted for each 
treatment. (C-H) Cells where treated as in (A, B) and analysed by Flow Cytometry with the 
PI/YO-PRO stains. Total alive (C) and dead (D) cells are shown, as well as Early apoptotic 
(E), late apoptotic (F) and end-stage apoptotic cells (G). (H). HEK293 cells where treated 
with non-targeting control siRNA (siNT) or REST siRNA, and with the RE1-Gaussia 
luciferase reporter. Cells were then exposed to hypoxia for 24 hours, and the activity of the 
reporter was measured. Successful REST knockdown is confirmed by the increased luciferase 
activity of the RE1-reporter, which is repressed in the presence of REST. Data are 
represented as mean ± SEM, n = 3 independent experiments. P-values are shown, p<0,05 is 
considered significant.  			 	
		
			
Figure S11. Validation of REST dependent hypoxia repressed genes. qRT-PCR was used 
to validate the mRNA expression of the indicated REST target genes. mRNA was isolated 
from HEK293 cells treated for 24 hours to normoxia (21% oxygen) or hypoxia (1% oxygen), 
in the presence or absence of an siRNA targeting REST. Data are represented as mean ± 
SEM, n = 4 independent experiments. P-values are shown, p<0,05 is considered significant 
over 1% oxygen siNT treated samples. 	
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